Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
BMC Genetics|September 4, 2015
Increased glycolipid storage produced by the inheritance of a complex intronic haplotype in the α-galactosidase A (GLA) geneJavier Gervas-Arruga, Jorge J Cebolla, Pilar Irun, et al.
Immunologic Research|December 15, 2015
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activityRicardo García-Muñoz, Ascensión López-Díaz-de-Cerio, Jesus Feliu, et al.
American Journal of Hematology|March 18, 2015
Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher diseaseDeborah Elstein, Atul Mehta, Derralynn A Hughes, et al.
Biochimica Et Biophysica Acta|July 25, 2006
Identification of chitotriosidase isoforms in plasma of Gaucher disease patients by two dimensional gel electrophoresisLucía Quintana, Alberto Monasterio, Kepa Escuredo, et al.
British Journal of Haematology|January 9, 2013
A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myelomaMaria T Petrucci, Pilar Giraldo, Paolo Corradini, et al.
Frontiers in Immunology|March 11, 2025
Neutrophil extracellular traps and macrophage activation contibute to thrombosis and post-covid syndrome in SARS-CoV-2 infectionIrene Serrano-Gonzalo, Bárbara Menéndez-Jandula, Esther Franco-García, et al.
International Journal of Molecular Sciences|October 29, 2025
Clinical Variability and Genotype-Phenotype Correlation in Spanish Patients with Type 1 Gaucher Disease: A Focus on Non-c.[1226A>G]; [1448T>C] GenotypesIrene Serrano-Gonzalo, Francisco Bauza, Laura Lopez de Frutos, et al.
American Journal of Hematology|November 2, 2017
Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)Ari Zimran, Nadia Belmatoug, Bruno Bembi, et al.
Blood Cells, Molecules & Diseases|August 9, 2016
Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher diseaseAri Zimran, Gloria Durán, Pilar Giraldo, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 17, 2010
Population-based incidence of childhood leukaemias and lymphomas in Spain (1993-2002)Rafael Marcos-Gragera, Marta Cervantes-Amat, Maria Luisa Vicente, et al.
Pageof 16